Bausch + Lomb to Hold Investor Day on Nov. 13

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New York Stock Exchange.

Chairman and CEO Brent Saunders will provide an update on the company’s transformation and strategic outlook, and Executive Vice President and Chief Financial Officer Sam Eldessouky will share details on a three-year plan to drive sustainable, profitable growth. Most of the event will be dedicated to Bausch + Lomb’s rebuilt product pipeline, with R&D leaders and commercial presidents highlighting potential game-changing innovations in each business unit. There will also be a panel of prominent eye care professionals discussing how the pipeline products could help elevate the standard of care in eye health.

Following the event, all materials and a replay of the webcast will be available on the Investor Relations section of the Bausch + Lomb website.

Investor Day Details

Date:	Thursday, Nov. 13, 2025
Time:	8:30 a.m. ET
Webcast registration:	https://www.webcaster5.com/Webcast/Page/2883/53072
Participant Event Dial-in:	[phone] (North America) [phone] (International)
Participant Access Code:	997785
Replay Dial-in:	[phone] (North America) [phone] (International)
Replay Passcode:	53072 (replay available until November 27, 2025)

About Bausch + Lomb

Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

Forward-looking Statements

This news release may contain forward-looking information and statements within the meaning of applicable securities laws (collectively, “forward-looking statements”). Forward-looking statements may generally be identified by the use of the words “anticipates,” “seeks,” “expects,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “potential,” “pending” or “proposed” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb’s filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

© 2025 Bausch + Lomb.